Typhoid vaccines now provide stronger, longer-lasting protection, especially for children in high-risk regions. The WHO-preferred Typbar TCV has shown high efficacy across diverse countries and age ...
Vaccinations used to seem simple. Your doctor would tell you which to get, and you’d roll up your sleeve at the office or a nearby pharmacy. Now we’re seeing changing recommendations, and some people ...
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to ...